Amalgamated Bank
- SEC CIK
- 0000919192
- Latest filing
- Jul 23, 2026
KYMR holding history
Kymera Therapeutics, Inc. in every 13F filed by Amalgamated Bank, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
KYMR overviewAll 13F holders of KYMRFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 19
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −1,772−100.0% | Sold out | Holders |
| Q4 2025 | 1,772 | $138.0K | <0.1% | +146+9.0% | Added | Holders |
| Q3 2025 | 1,626 | $92.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 1,626 | $71.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 1,626 | $45.0K | <0.1% | +233+16.7% | Added | Holders |
| Q4 2024 | 1,393 | $56.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 1,393 | $66.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 1,393 | $42.0K | <0.1% | +68+5.1% | Added | Holders |
| Q1 2024 | 1,325 | $53.0K | <0.1% | −4,099−75.6% | Reduced | Holders |
| Q4 2023 | 5,424 | $138.0K | <0.1% | −394−6.8% | Reduced | Holders |
| Q3 2023 | 5,818 | $81.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 5,818 | $134.0K | <0.1% | +1,889+48.1% | Added | Holders |
| Q1 2023 | 3,929 | $116.0K | <0.1% | −923−19.0% | Reduced | Holders |
| Q4 2022 | 4,852 | $121.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 4,852 | $106.0K | <0.1% | +48+1.0% | Added | Holders |
| Q2 2022 | 4,804 | $95.0K | <0.1% | −798−14.2% | Reduced | Holders |
| Q1 2022 | 5,602 | $237.0K | <0.1% | −436−7.2% | Reduced | Holders |
| Q4 2021 | 6,038 | $383.0K | <0.1% | −79−1.3% | Reduced | Holders |
| Q3 2021 | 6,117 | $359.0K | <0.1% | +657+12.0% | Added | Holders |
| Q2 2021 | 5,460 | $265.0K | <0.1% | +5,460 | New | Holders |